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ABSTRACT
Nonsense-mediated mRNA decay (NMD) is a surveil-
lance pathway that recognizes and selectively
degrades mRNAs carrying premature termination
codons (PTCs). The level of sensitivity of a PTC-
containing mRNA to NMD is multifactorial. We have
previously shown that human -globin mRNAs car-
rying PTCs in close proximity to the translation ini-
tiation AUG codon escape NMD. This was called the
‘AUG-proximity effect’. The present analysis of non-
sense codons in the human -globin mRNA illus-
trates that the determinants of the AUG-proximity ef-
fect are in fact quite complex, reflecting the ability of
the ribosome to re-initiate translation 3′ to the PTC
and the specific sequence and secondary structure
of the translated ORF. These data support a model
in which the time taken to translate the short ORF,
impacted by distance, sequence, and structure, not
only modulates translation re-initiation, but also im-
pacts on the exact boundary of AUG-proximity pro-
tection from NMD.
INTRODUCTION
The classical model of nonsense-mediated mRNA decay
(NMD) in mammalian cells stipulates that the relationship
of a nonsense codon to exon–exon junctions in a PolII tran-
script dictates whether it will be recognized as ‘premature’
and trigger rapid decay. This decay, when it occurs, is trig-
gered by an interaction of the translation termination com-
plex at the stop codon with a retained exon junction com-
plex (EJC) on the mRNA (1–6). These protein interactions
appear to be critical to the discrimination of a premature
translation termination event from a normal one (1–3,5,6).
The EJC is deposited 20–24 nucleotides (nts) upstream of
the exon–exon junction(s) during splicing and remains as-
sociated with the mRNA during its transport to the cyto-
plasm (1–3). Translating ribosomes subsequently displace
EJCs from the open reading frame (ORF) during the pio-
neer round of translation. If a stop codon is located more
than 50–54 nts upstream of at least one exon–exon junc-
tion, the leading edge of the elongating ribosome will fail
to displace it. In this case, when the ribosome reaches the
termination codon, the translation eukaryotic release fac-
tors eRF1 and eRF3 at the stop codon interact in cis with
the retained EJC(s) via bridging interactions between the re-
lease complex associated proteins, UPF1 and SMG-1 and
the EJC-associated factors, UPF2-UPF3 (7,8). This bridg-
ing interaction triggers accelerated decay (i.e. NMD) of the
nonsense-containingmRNA through the recruitment of ad-
ditional factors (9–19).
In addition to the EJC-dependent NMDmodel, an EJC-
independent NMD pathway postulates that identification
of a stop codon as ‘premature’ depends on the physical dis-
tance between the stop codon and the cytoplasmic poly(A)-
binding protein 1 (PABPC1) bound to the poly(A) tail (20–
25). This ‘faux 3′ UTR’ model proposes that PABPC1 and
UPF1 compete for interaction with eRF3 at the site of
translational termination: if PABPC1 is in close proxim-
ity to a stop codon, it interacts with the termination com-
plex, stimulates translation termination (26), and represses
NMD; alternatively, when the interaction of PABPC1 with
the termination complex is reduced, for example due to a
long 3′ untranslated region (3′ UTR), UPF1 interacts with
eRF3 and triggers NMD (20–25). Recent studies that map
UPF1 binding throughout the mRNA (5′ UTRs, coding
regions and 3′ UTR) (27–29) irrespective of NMD (28)
seem to challenge this mechanistic model of NMD. Nev-
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ertheless, elongating ribosomes displace UPF1 from cod-
ing sequences causing its enrichment in 3′ UTRs (28); thus,
transcripts with long 3′ UTRs might increase the probabil-
ity that UPF1 will outcompete PABPC1 for release factor
binding and trigger NMD.
Consistent with the faux 3′ UTR model of NMD is
the fact that endogenous NMD substrates are enriched in
mRNAs containing long 3′ UTRs (30–33). This model is
also supported by the observation that artificially tether-
ing PABPC1 in close proximity to a premature termina-
tion codon (PTC) can inhibit NMD through a mechanism
that involves its eRF3-interacting C-terminal domain (21–
24,34). However, recent data have shown that interaction of
PABPC1with eRF3 is not strictly necessary for the tethered
PABPC1 to suppress NMD (35), as NMD suppression may
also be mediated via PABPC1 interaction with the eukary-
otic initiation factor 4G (eIF4G) (36,37). Furthermore, it
has been suggested that a key NMD determinant might be
the efficiency of ribosome release at the PTC (38), which is
an event where UPF1 seems to have a role (39). These and
other observations (reviewed in reference 38) reinforce the
conclusion that the mechanisms that dictate NMD strength
are complex and not well defined.
The pivotal role that PABPC1 plays inNMD suppression
when in close proximity to a stop codon can also be high-
lighted by the ‘AUG-proximity effect’. Studies from our lab-
oratory have shown that human -globin (h-globin) mR-
NAs containing nonsense mutations early in exon 1 accu-
mulate to levels similar to those of wild-type (WT) -globin
transcripts (40). This resistance to NMD is erythroid- and
promoter-independent, and does not reflect translation re-
initiation, abnormal RNA splicing, or impaired transla-
tion (41). Instead, the observedNMD-resistance reflects the
close proximity of the nonsense codon to the translation ini-
tiation codon (41). This was called the ‘AUG-proximity ef-
fect’ (21). Consistent with the repressive impact of PABPC1
on NMD (see above) (20–24) our mechanistic studies re-
vealed that the AUG-proximity effect results the juxtaposi-
tion of PABPC1 with the AUG-proximal PTC as a conse-
quence of mRNA circularization and the inherent nature of
the short ORF translation process (21,34).
In the present report, we carry out a detailed comparison
of the AUG-proximity effect on NMDof the human - and
-globinmRNAs.While the data support a generality of the
AUG-proximity effect on NMD, this detailed comparison
also highlights variables of mRNA sequence and structure
that factor into this pathway of NMD resistance. The im-
pact of these variables appears to reflect the time taken for
the 80S ribosome to translate the short ORF prior to en-
countering the PTC.
MATERIALS AND METHODS
Construction of expression vectors
The 1677-bp EcoRI/RcaI fragment containing the whole
wild-type 2-globin gene was obtained from plasmid
pTet-WT (42) and sub-cloned into EcoRI/BspLU11I
sites of the pTRE2pur vector (BD Biosciences),
originating the pTRE-WT plasmid. Constructs 4
(CCU→UAG), 7 (AAU→UAG), 10 (GUC→UAG),
12 (GCC→UAG), 14 (UGG→UAG), 14/40
(UGG→UAG, AAG→UAG), 16 (AAG→UAA), 19
(GCG→UAG), 21 (GCU→UAG), 23 (GAG→UAG),
25 (GGU→UAG), 27 (GAG→UAG), 30
(GAG→UAG), 32 (AUG→UAG), 36 (UUC→UAG),
40 (AAG→UAG), 45 (CAC→UAG), 50
(CAC→UAG), 55 (GUU→UAG), 60 (AAG→UAG),
65 (CGC→UAG), 70 (GUG→UAG), 73
(GUG→UAG), 76 (AUG→UAG), 78 (AAC→UAG),
80 (CUG→UAG), 82 (GCC→UAG), 84
(AGC→UAG), 86 (CUG→UAG), 93 (GUG→UAA),
101 (CUA→UAG) and 116 (GAG→UAG), carrying the
denoted nonsense mutations at codon positions indicated
by the respective number, were created by site-directed
mutagenesis, as recommended by the kit manufacturer
(QuikChange Site-Directed Mutagenesis Kit; Stratagene),
with mutagenic primers #1-#62 (Supplementary Table
S1), using the plasmid pTRE-WT as DNA template.
Potential re-initiation sites in -globin codons 32 and 76
were sequentially mutated, from AUG (methionine: Met)
to ACG (threonine: Thr), in cis by site-directed mutage-
nesis with primers #63-#66, using pTRE-WT, 14, 27
or 40 as templates, to create the constructs WT.32–
76Met→Thr, 14.32–76Met→Thr, 27.32–76Met→Thr
and 40.32–76Met→Thr.
The WT-pseudoknot (pk), 25-pk, 27-pk and 40-pk
gene variants were prepared by replacing the first 19 codons
of the native -globin ORF by a 19-codon sequence re-
sulting in a pseudoknot structure in the mRNA (43), by
overlap-extension polymerase chain reaction (PCR) with
overlapping primers #67 and #68 (Supplementary Table
S1) and the WT, 25, 27 or 40 genes as DNA templates.
The WT-(CAA)26 and 40-(CAA)26 gene variants were
obtained by replacing the first 26 codons of the -globin
ORF with 26 consecutive ‘CAA’ repeats, also by overlap-
extension PCR, with overlapping primers #69 and #70 and
theWTor40 genes asDNA templates. The27-(CAA)26
gene was created with overlapping primers #71 and #72
and the WT-(CAA)26 gene as DNA template. The WT-
(CAA)26–32–76Met→Thr, 27-(CAA)26–32–76Met→Thr
and 40-(CAA)26–32–76Met→Thr gene variants were pro-
duced with overlapping primers #63 and #64 and the WT-
(CAA)26, 27-(CAA)26, WT.32–76Met→Thr or 40-
(CAA)26–32–76Met→Thr genes as DNA templates. For all
the above mentioned -globin gene variants prepared by
overlapping PCR, flanking primers #73 and #74 were used
and a 923-bp KpnI/ApaI fragment of each PCR product
was cloned into the KpnI/ApaI sites of the pTRE-WT
plasmid.
The wild-type -globin gene (WT), as well as the
previously described human -globin variants 15
(UGG→UGA) and 39 (CAG→UAG) (41), were sub-
cloned into the ClaI/BspLU11I sites of pTRE2pur vector
(BD Biosciences) by PCR amplification of the 1806-bp
ClaI/BspLU11I fragment, using primers with linkers for
ClaI and BspLU11I (primers #75 and #76; Supplementary
Table S1). The -globin variants 23 (GUU→UAG),
25 (GGU→UAG) and 26 (GAG→UAG), carrying the
denoted nonsense mutations at codon positions 23, 25 and
26, respectively, were created by site-directed mutagenesis
using mutagenic primers #77-#82 and the construct WT
as DNA template. The WT-pk, 23-pk and 39-pk gene
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variants were constructed by replacing the first 19 codons
of a native -globin ORF by a 19-codon sequence resulting
in a pseudoknot structure in the mRNA (43), using the
ExSite PCR-Based Mutagenesis Kit (Stratagene) as indi-
cated by themanufacturer, with mutagenic primers #83 and
#84, and the WT and 39 genes as DNA templates, or
primers #83 and #85 using the 23 gene as DNA template.
The WT-(CAA)25 and 39-(CAA)25 gene variants were
obtained by replacing the first 25 codons of the native
-globin ORF with 25 consecutive ‘CAA’ repeats, by
overlap-extension PCR with overlapping primers #86 and
#87, and the WT or 39 genes as DNA templates. The
26-(CAA)25 gene was prepared with overlapping primers
#88 and #89, and the WT-(CAA)25 gene as template.
Flanking primers #73 and #90 were used and a 478-bp
ClaI/BbrPI fragment of each PCR product was cloned
into the ClaI/BbrPI sites of the WT construct.
The hybrid genes 5′ UTR-/WT, 5′ UTR-/27, 5′
UTR-/40, WT26/, 26/‘27’ and WT26/40 were
obtained by replacing the 5′ untranslated region (5′ UTR)
or the first 26 codons plus the 5′ UTR of the respec-
tive -globin gene variants by the equivalent -globin se-
quences. This was achieved by overlap-extension PCR with
overlapping primers #91-#96 (Supplementary Table S1)
and flanking primers #73 and #74, and the WT, 27,
40, WT or 26 genes as DNA templates. Additionally,
5′ UTR-/WT26/, 5′ UTR-/26/‘27’ and 5′ UTR-
/WT26/40 genes were shaped by replacing the 5′ UTR
of WT26/, 26/‘27’ and WT26/40, respectively,
with the native 5′ UTR of -globin. Overlapping primers
#97 and #98 were used together with flanking primers #73
and #74 on WT, WT26/, 26/‘27’ and WT26/40
template genes. A 1094-bp XbaI/BbrPI fragment of each
PCR product was cloned into the XbaI/BbrPI sites of
the WT construct. The hybrid genes 5′ UTR-/WT, 5′
UTR-/26, 5′ UTR-/39, WT27/, 27/‘26’ and
WT27/39 were produced reciprocally to /-globin hy-
brid genes, with overlapping primers #97-#102 and flank-
ing primers #73 and #90, and the WT, 26, 39, WT
or 27 genes as DNA templates. Furthermore, the hy-
brid genes 5′ UTR-/WT27/, 5′ UTR-/27/‘26’ and
5′ UTR-/WT27/39 were obtained using overlapping
primers #91 and #92, flanking primers #73 and #90, and
the WT, WT27/, 27/ and WT27/39 genes as tem-
plates. The 1110-bp XbaI/BbrPI fragment of each PCR
product was inserted into the XbaI/BbrPI sites of the WT
construct.
The 514-bp XhoI/HindIII fragment containing the
PhCMV*-1 tetracycline (tet)-responsive promoter was ob-
tained from the pTRE2pur vector (BD Biosciences) and
sub-cloned into XhoI/HindIII sites of the pGL2-Enhancer
vector (Promega), which contains the firefly luciferase gene,
and into XhoI/HindIII sites of the pGL4.70[hRluc] vector
(Promega), which contains the Renilla luciferase gene, orig-
inating the pGL2TRE and the pGL4TRE plasmids, respec-
tively.
The -globin/luciferase (Luc) hybrid genes, 14/Luc,
27/Luc, 27-(CAA)26/Luc and 27-pk/Luc, were ob-
tained by replacing the -globin sequence downstream
to codon 32 with the firefly luciferase ORF, by overlap-
extension PCR with overlapping primers #103 and #104
(Supplementary Table S1) and the 14, 27, 27-(CAA)26
and 27-pk or pGL2TRE constructs as DNA templates.
The respective positive and negative controls for luciferase
activity were created with overlapping primers #105-#108
and the 14/Luc or 27/Luc genes as DNA templates.
Flanking primers #73 and #109 were used and a 752-bp
XhoI/XbaI fragment of each PCR product was cloned into
the XhoI/XbaI sites of the pGL2TRE plasmid.
The -globin/Luc hybrid genes, 15/Luc, 23/Luc and
26/Luc, were prepared by replacing the -globin sequence
downstream to codon 55 with the firefly luciferase ORF,
by overlap-extension PCR with overlapping primers #110
and #111 (Supplementary Table S1) and the 15, 23, 26
or pGL2TRE constructs as DNA templates. The respec-
tive positive and negative controls for luciferase activity
were produced with overlapping primers #112-#115 and
the 15/Luc, 23/Luc or 26/Luc genes as DNA tem-
plates. Flanking primers #73 and#109were used and a 906-
bp XhoI/XbaI fragment of each PCR product was cloned
into the XhoI/XbaI sites of the pGL2TRE plasmid.
Cell culture and transfections
Mouse erythroleukemia (MEL) cells stably expressing the
tet transactivator (MEL/tTA) (42) were used for condi-
tional expression of human -globin genes (previously
cloned into the pTRE2pur vector). For transient transfec-
tions, MEL/tTA cells were split 1 day before transfection
and cultured in minimal essential medium (MEM) supple-
mented with 10% (v/v) fetal bovine serum, and 100 ng/ml
tetracycline (tet). Cells were transfected with 2g of pTRE-
WT, or each variant, as previously described. Then, cells
were split into 60-mm-diameter dishes, and pulsed with -
globin mRNA for 4 h by growth in tet(-) media. Following
this period, transcription from the plasmid was blocked by
the addition of tet to themedia. Cells from each culture dish
were harvested in different time points for further analyses.
HeLa cells, stably expressing the tet transactivator
(HeLa/tTA) (42), were grown in Dulbecco’s modified Ea-
gle’s medium (DMEM) supplemented with 10% (v/v) fe-
tal bovine serum. Transient transfections were performed
using Lipofectamine 2000 Transfection Reagent (Invitro-
gen), following the manufacturer’s instructions, in 35-mm
plates. For genes cloned into the pTRE2pur vector, 150 ng
of the test construct DNA were cotransfected with 1850
ng of pEGFP plasmid DNA (BD Biosciences) as a con-
trol for monitoring transfection efficiency, and cells were
harvested after a 20 h transcription pulse. For gene con-
structs cloned into the pGL2TRE plasmid, 2 g of the
test construct DNA were cotransfected with 50 ng of the
pGL4TRE plasmid as a control for luminescence, and cells
were harvested after a 16 h transcription pulse. When ap-
propriated, transcription was blocked by the addition of
tet or 50 g/ml adenosine analogue 5,6-dichloro-1–3-D-
ribofuranosylbenzimidazole (DRB) to the media and cells
were harvested in different time points after treatment.
Transfection of siRNA
Transient transfections of siRNAs were carried out us-
ing Lipofectamine 2000 reagent (Invitrogen) according to
Nucleic Acids Research, 2015, Vol. 43, No. 13 6531
the manufacturer’s instructions in 35-mm plates using 100
pmol of siRNA oligonucleotides and 4 l of transfec-
tion reagent. Twenty-four hours later, cells were transfected
again with 50–75 pmol of siRNAs, 150 ng of the test con-
struct DNA and 1000 ng of pEGFP vector. After additional
24 h, cells were harvested for analysis of RNA and protein
expression. When appropriated, HeLa cells were treated
with 50 g/ml DRB and RNA was thereafter extracted
at different time points for further analysis. The siRNA
oligonucleotides used for transfections [Luciferase (5′-AA-
CGUACGCGGAAUACUUCGA-3′) and hUPF1 (5′-AA-
GAUGCAGUUCCGCUCCAUU-3′)] were purchased as
annealed, ready-to-use duplexes from Dharmacon.
RNA isolation
Total RNA from transfected cells was prepared using the
RNeasy mini kit (Qiagen) following the manufacturer’s
indications. RNA samples were treated with RNase-free
DNase I (Ambion) and purified by phenol:chloroform ex-
traction. Before further analyses, mRNA samples were
tested by reverse-transcription (RT) followed by PCR (RT-
PCR) to reject the hypothesis of activation of cryptic splic-
ing pathway(s), with consequent alteration in mRNA se-
quence and possible circumvention of the premature ter-
mination codon. From all transcript species a single full-
length productwas amplified (data not shown), demonstrat-
ing that the studied nonsense transcripts present a normal
splicing pattern.
Ribonuclease protection assay (RPA)
The -globin probe is a 174-bp fragment encompassing the
3′ part of exon 3 inserted into the polylinker region of pTRI-
amp-18 (Ambion) and was generated by in vitro transcrip-
tion, using a Maxiscript T7 or SP6 kit (Ambion), accord-
ing to the manufacturer’s standard protocol. The -globin
probe was produced using a Maxiscript SP6 kit (Ambion)
and consists of a 170 bp fragment encompassing the last
20 bp of intron 2, the entire exon 3 coding region, and the
first 21 bp of 3′ UTR, which was amplified by PCR and
inserted into the polylinker region of pGEM3 (Promega).
The puroR probe was generated using a Maxiscript T7 kit
(Ambion), comprises a 280 bp puromycin-resistance gene
fragment cloned into pGEM3 and protects 197 nt of the
puromycin-resistance mRNA. Samples were processed as
described elsewhere (41,44).
Western blot analysis
Protein lysates were resolved, according to standard pro-
tocols, in 10% SDS-PAGE, and transferred to polyvinyli-
dene difluoride (PVDF) membranes (Bio-Rad). Mem-
branes were probed using mouse monoclonal anti--
tubulin (Roche) at 1:10000 dilution, and goat polyclonal
anti-hUPF1 (Bethyl Labs) at 1:500 dilution. Detection was
carried out using secondary peroxidase-conjugated anti-
mouse IgG (Bio-Rad) or anti-goat IgG (Sigma) antibodies
followed by chemiluminescence.
Semi-quantitative RT-PCR
The reverse-transcription (RT) of 500 ng of RNA from
HeLa cells cotransfected with pGL2TRE (or - and -
globin/Luc hybrid variants; containing the firefly luciferase
gene) and pGL4TRE (which contains the Renilla luciferase
gene) was performed with Superscript II (Invitrogen), un-
der conditions recommended by the manufacturer, using 2
pmol of reverse primers #109 and#116 (Supplementary Ta-
ble S1) in a final volume of 10 l. The PCR reactions for
firefly and Renilla luciferases were executed in parallel at
similar conditions: 1 l of the RT product was amplified
in a 25 l reaction volume using 0.2 mM dNTP mixture,
1.5 mMMgCl2, 10 pmol of each primer (primers #109 and
#117 for the firefly luciferase and primers #116 and #118
for Renilla luciferase), 0.75 U of GoTaq DNA Polymerase
(Promega) and 1x Reaction Buffer (Promega). Thermocy-
cler conditions were 95◦C for 3 min, followed by 29 cycles
of 95◦C for 30 s, 58◦C for 45 s and 72◦C for 45 s, followed
by a final extension of 72◦C for 10 min. Samples were re-
solved by electrophoresis in 1% agarose gels stained with
ethidium-bromide, which were then digitalized and densito-
metric analysis was performed using ImageQuant software
(Molecular Dynamics).
Reverse transcription-coupled quantitative PCR (RT-qPCR)
First-strand cDNA was synthesized from 2 g of total
RNA using the SuperScript II Reverse Transcriptase
(Invitrogen) according to the manufacturer’s instructions.
Real-time PCR was performed with the ABI7000 Sequence
Detection System (Applied Biosystems) using SYBR
Green PCRMaster Mix (Applied Biosystems). The relative
expression levels of -globin and -globin mRNAs were
normalized to the internal control puromycin-resistance
mRNA in HeLa cells and calculated using the com-
parative CT method (2−CT) (45). The CT values of
variant -globin and -globin mRNAs amplicons were
compared to the respective WT, WT counterpart or
to WT Luc siRNA, WT Luc siRNA as indicated
in figures and normalized with the reference amplicon
CT value. The amplification efficiencies of the -globin,
-globin targets and puromycin-resistance reference am-
plicons were determined for each assay by dilution series.
The forward and reverse primers for human -globin
mRNA were 5′-GTGGATCCTGAGAACTTCAGGCT-
3′ and 5′-CAGCACACAGACCAGCACGT-3′ and for
-globin were 5′-CCCGGTCAACTTCAAGCTCC-
3′ and 5′-CAGCACGGTGCTCACAGAAG-3′.
In addition, we have used the following primers:
5′-CGCAA CCTCCCCTTCTACG-3′ and 5′-
GGTGACGGTGAAGCCGAG-3′ for puromycin-
resistance mRNA. The following cycling parameters
were used: 10 min at 95oC and 40 cycles of 15 s at 95oC and
1 min at 60oC. Technical triplicates from three indepen-
dent experiments were assessed in all cases. To check for
DNA contamination, quantitative PCR without reverse
transcription was also performed.
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Luminometry assays
HeLa cells were lysed with Passive Lysis Buffer (Promega)
and luminescence was measured in a Lucy 2 luminometer
(Anthos Labtec) with the Dual-Luciferase Reporter Assay
System (Promega), according to the manufacturer’s stan-
dard protocol, using automatic injectors.
RESULTS
TheAUG-proximity boundaries that dictate NMD resistance
differ between human - and -globin mRNAs
We have previously reported that human -globin mRNAs
carrying nonsense mutations in proximity to the initiation
AUG are resistant to NMD and are expressed at levels ap-
proaching those of the wild-type -globin (WT) mRNA
(40,41). To further characterize this ‘AUG-proximity effect’
and to define its parameters, we compared the boundary of
this effect in human -globin and -globin mRNAs.
The boundaries were mapped by assessing expression of
corresponding series of - and -globin mRNAs (Figure
1). The analysis of the -globin mRNAs (summarized in
Figure 1B) revealed that 15 and 23 mRNAs accumu-
late at normal levels, more specifically at 105% and 93%
of the WT mRNA, respectively (Figure 1B), while lev-
els of 25, 26, and 39 mRNAs were drastically lower,
at 21%, 20% and 22% of WT mRNA, respectively (Fig-
ure 1B). The stabilization of 25, 26 and 39 mRNAs in
UPF1-depleted cells to WT levels confirmed that the low
levels were due to NMD (Supplementary Figure S1A and
B). Targeted comparison of 15 and 39 mRNAs further
confirmed the distinction of NMD sensitive and NMD re-
sistant mRNAs related to their AUG-proximity (Supple-
mentary Figure S1C). Together, these data map the bound-
ary of the AUG-proximity effect for NMD resistance of -
globin mRNA between codons 23 and 25.
In a separate experiment, wemapped the boundary of the
AUG-proximity effect for NMD resistance in the h-globin
mRNA. Results revealed that -globin mRNAs carrying a
PTC located at exon 1 (exon 1 encompasses 30 codons) ac-
cumulate to steady-state levels of 57% to 95% of normal
control that are significantly above typical NMD levels (35)
(Figure 1C). In contrast, mRNAs containing nonsense mu-
tations in the first half of exon 2, between codons 32 and
70, appear to be fully sensitive to NMD with levels ranging
from 27% to 40% of the WT levels (Figure 1C). Nonsense
mutations positioned further into exon 2 achieved higher
levels, most likely reflecting an inhibition of NMD as the
PTC comes within 50–55 nts of the last exon–exon junction
(Figure 1C). As predicted by the EJC model of NMD, the
PTCs located 3′ to codon 82 accumulated to normal levels
(Figure 1C).
To confirm that the steady-state mRNA levels beingmea-
sured reflected the corresponding stabilities of the PTC-
containing h-globin mRNAs, we measured the absolute
half-lives of selected mRNAs. The half-life of the 32
mRNA (3.5 h) and 40 mRNA (2.0 h) (46) were consis-
tent with a full sensitivity to NMD (Supplementary Figure
S2A) and contrasted with the half-lives of 27 (7.5 h) and
30 (7.0 h). The intermediate half-lives of 73 (5.5 h) and
80 (6.2 h) mRNAs are likely to reflect stabilization as the
PTC is moved closer to the terminal EJC (47,48).
To directly demonstrate that -globin transcripts carry-
ing a PTC in exon 1 escape NMD, we analyzed the im-
pact of UPF1-depletion in HeLa cells (Supplementary Fig-
ure S2B). In cells treated with control Luc siRNAs, the 7,
10, 12, 14, and 16 mRNAs accumulated to levels 86%
to 98% of the WT control, contrasting with 30% for the
NMD-sensitive40mRNA.UPF1 depletion had no appre-
ciable impact on the levels of the 7, 10, 12, 14, and 16
mRNAs (Supplementary Figure S2C). Levels of 23, 27
and 30 mRNAs in the control siRNA-treated cells were
intermediate (77%, 67% and 66%) (Supplementary Figure
S2C), consistent with partial NMD sensitivity. Consistent
with this conclusion was the observation that UPF1 deple-
tion resulted in a significant increase in the accumulation
levels of 23, 27, 30, and 40 mRNAs (Supplementary
Figure S2C), as well as in a significant increase in the half-
lives of 27, and 40 mRNAs, while that of the 16 mRNA
did not significantly change (Supplementary Figure S2D).
Taken together, these data are consistent with NMD-
resistance of PTCs located in close proximity to the AUG.
In the case of the h-globin mRNA, PTCs extending to at
least codon 16 escape the full impact of NMD and PTCs
located more distal to the AUG in exon 1 demonstrate par-
tial commitment to NMD. Of note, the boundary for the
AUG-proximity effect appears to differ between the two hu-
man globin mRNAs; the boundary of the AUG-proximity
effect for NMD resistance in h-globin mRNA maps be-
tween codons 23 and 25, contrasting with the boundary fur-
ther 3′ (between codons 30 and 32) in the h-globinmRNA.
Defining the basis for this difference has potential to the full
understanding of the NMD pathway response.
The human -globin mRNAs can activate efficient transla-
tional re-initiation 3′ to an AUG-proximal PTC
Translation re-initiation downstream of a PTC has the
potential to inhibit NMD via disruption of downstream
EJC(s) (49). We have previously shown that translation re-
initiation does not occur 3′ to AUG-proximal nonsense mu-
tations in h-globin mRNAs (for example, 15 mRNA)
(41). In contrast, re-initiation can occur in the h-globin
mRNA (46). Such re-initiationmight account for the differ-
ence in the NMD resistance boundary. To test this possibil-
ity, we first focused our studies on the -globin mRNAwith
a PTC at the 3′ part of exon 1, at codon 27. The PTC at this
position in h-globin mRNA is partially NMD-resistant
and is 3′ to the AUG-proximity boundary determined for
the h-globin mRNA. We mutated the putative initiating
AUG codons located downstream of the PTC, which are lo-
cated at positions 32 and 76. The 32Met and 76Met AUG-
to-ACG conversions created the 27.32–76Met→Thr gene
(Figure 2A). Its expression was compared to that of the
WT.32–76Met→Thr, 14.32–76Met→Thr, and 40.32–
76Met→Thr control genes previously described (46). The
40.32–76Met→Thr mRNA was expressed at the same
level as 40 mRNA (33% of WT), consistent with no
translation re-initiation at codon 76 and full NMDcommit-
ment (Figure 2B). On the other hand, 14.32–76Met→Thr
transcripts accumulate at about 71% of WT, and at about
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Figure 1. Fine-mapping reveals differences in the boundary of the AUG-proximity effect for NMD resistance in the human - and -globin mRNAs. (A)
Schematic representation of the studied human -globin mRNAs. Vertical lines represent translation initiation (AUG) or termination [native (UAA) or
premature (PTC)] codons. The designation of each transcript is indicated to the right. (B) Representative ribonuclease-protection assay (RPA) using RNA
isolated fromHeLa cells transiently transfected with the constructs specified beneath each lane [the plasmid also contains the puromycin-resistance (puroR)
gene]. The identification of -globin and the puromycin-resistance (puroR) protected fragments is indicated to the left of the autoradiograph. Resulting
levels of -globin mRNA quantified relatively to the puroR mRNA, and normalized to the expression level of the wild-type mRNA (WT), are plotted
above each respective lane. The average values and standard deviations from three independent experiments are shown. A 2-fold RNA sample (2x WT)
from HeLa cells transfected with the WT gene was also assayed to demonstrate that the experimental RPA was carried out in probe excess. (C) HeLa
cells were transfected with the -globin constructs (also containing the puroR gene) specified above each lane. Total RNA from transiently transfected
HeLa cells was isolated and analyzed by RPA as above in (B). The percentage mRNA values were plotted for each construct, and standard deviations from
four independent experiments are shown. Below the graph, the schema represents the studied human -globin mRNA. Vertical lines represent translation
initiation (AUG) or termination (UAA) codons, which are aligned with the X-axis of the graph that shows the mRNA nonsense-mutated codons.
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Figure 2. Contrary to what occurs in -globinmRNA, -globinmRNAs allow for efficient translation re-initiation, but only partially contributes toNMD
inhibition. (A) Schematic representation of the studied human -globinmRNAs. Vertical lines represent translation initiation (AUG) or termination [native
(UAA) or premature (PTC)] codons. The conversion of the two potential re-initiation AUGs, at codons 32 and 76, to ACG codons is indicated by short and
thick vertical lines. The name of each transcript is specified on the right. (B) A representative RPA of RNA isolated fromHeLa cells transiently transfected
with each gene construct is shown. Identification of the -globin and the puromycin-resistance (puroR) protected fragments is indicated to the right of the
autoradiograph. Levels of -globin mRNAwere quantified relatively to the puroR mRNA, and these values are plotted above each respective lane (average
and standard deviations) normalized to the expression level of the WT gene. A 2-fold RNA sample (2x WT) from HeLa cells transfected with a WT
gene was also analyzed to demonstrate that the experimental RPA was carried out in probe excess. For each case, three independent experiments were
performed. P-values were determined using a student’s t-test and refer to the comparison with the corresponding original nonsense-mutated transcript
levels, after normalization to the wild-type control. (C) The 5′-part of -globin gene upstream of codon 32 (AUG), or upstream of codon 55 (AUG) of
-globin gene, was fused with the firefly luciferase open reading frame (ORF). Volume-shaped rectangles represent luciferase ORFs, dark-gray rectangles
represent -globin exons and light-gray rectangles represent -globin exons. The initiation or potential re-initiation, as well as termination [native (UAA)
or premature (PTC)] codons, are represented as black vertical lines. A positive control construct was created for each hybrid gene, in which the translation
initiation codon for - or -globin gene was mutated to AUA. HeLa cells were transiently cotransfected with firefly and Renilla luciferase-containing
plasmids. Luciferase activity was analyzed 16 h after transfection. In parallel, both firefly and Renilla luciferase mRNA levels were determined by semi-
quantitative RT-PCR. The activities of firefly and Renilla luciferase were calculated relative to their respective mRNA levels (Relative mRNA Levels, left
bars), and then the resulting values for firefly luciferase activity/mRNAwere quantified relative to those ofRenilla luciferase activity/mRNA. The obtained
luciferase relative activities from hybrid mRNAs were normalized to the relative activity of the uncoupled firefly luciferase (Luc). The average values and
standard deviations from three independent experiments corresponding to three independent sets of transfections are shown.
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80% of 14 mRNA, as previously described (46), showing
that blocking potential translation re-initiation sites results
in partial NMD triggering of the 14 mRNA. Consistent
with this conclusion is the observation that UPF1 deple-
tion resulted in a significant increase in the accumulation of
14.32–76Met→Thr mRNA (Supplementary Figure S3B).
In addition, we observed that 27.32–76Met→Thr mRNA
accumulates at about 56% of WT, and at about 85% of 27
mRNA (Figure 2B). Of note, expression of the 27 mR-
NAs with the double missense mutation remains well above
the levels of the 40 mRNA, indicating that translation re-
initiation does not fully explain their NMD resistance.
To better quantify the impact of translation re-initiation
on 14 and 27 mRNA accumulation, we used a luciferase
reporter assay. The first in site for potential re-initiation
downstream of 14 and 27 is at codon 32Met. Thus, we
created a set of 14/Luc and 27/Luc constructs in which
the -globin gene upstream of codon 32 was fused with
the firefly luciferase ORF (Figure 2C). After transient ex-
pression of these constructs in HeLa cells, luciferase activ-
ities were measured and normalized to the corresponding
mRNA levels. Results show that the 14/Luc and 27/Luc
constructs carrying the 0Met codon mutated to AUA, al-
low for 104% and 108% of the uncoupled luciferase rela-
tive activity, respectively. In addition, both 14/Luc and
27/Luc constructs lead to the production of consider-
able high amounts of luciferase, being about 75% and 62%
of the uncoupled luciferase activity, respectively (Figure
2C). Taken together, these results demonstrate that transla-
tion can efficiently re-initiate at codon 32Met in h-globin
mRNA. Our data further reveal that the efficiency of trans-
lation re-initiation decreases when the ORF is lengthened
and the intercistronic region is shortened, as has been pre-
viously described (43,50).
An equivalent analysis was performed to show the in-
effectiveness of -globin mRNA to re-initiate translation
at codon 55Met as previously defined (41). Indeed, we ob-
served that 15/Luc and 23/Luc constructs result in very
low amounts of luciferase activity, at about 7% and 5%, re-
spectively, when compared with the relative activity result-
ing from the uncoupled luciferase gene (Figure 2C). Also,
these levels are similar to those obtained from the 26/Luc
construct, which shows a luciferase activity of 4% (Figure
2C). The very low luciferase activity given by 26/Luc con-
struct is not surprising, as 26 transcripts are efficiently de-
graded by NMD. Thus, NMD-resistant (15 and 23 mR-
NAs) and NMD-sensitive transcripts (26) show similar
low levels of translation re-initiation.
This set of experiments lead us to conclude that the level
of mRNA accumulation for h-globin mRNAs with AUG-
proximal PTCs, and the corresponding resistance to NMD,
is impacted to some extent by the potential to re-initiate
translation 3′ to the AUG-proximal PTC.
Human -globin mRNAs carrying an AUG-proximal PTC
do not allow for ribosomal read-through of the PTC
Ribosomal read-through of a nonsense codon can in theory
inhibit NMD, by displacing the downstream located EJC(s)
(49) and consequently preventing the interaction of UPF1
with the terminating complex and with the UPF2/UPF3
components of the EJC (7). We have previously shown that
the h-globin mRNA carrying the 15 mutation in cis to
the 39 mutation does not allow ribosomal read-through
of the 15 PTC (41). These results have been subsequently
confirmed by others (51). Here, we assessed the potential
contribution of PTC read-through to NMD resistance of
AUG-proximal PTCs in the h-globin mRNA. We con-
structed an expression vector containing two PTCs in cis,
one at codon 14 and another at codon 40 (construct14/40;
Figure 3A). The encoded mRNA was expressed in HeLa
cells, in parallel with the WT, 14 and 40 control con-
structs (Figure 3B). Read-through of the PTC at position 14
would be expected to destabilize the double mutant 14/40
mRNA because the PTC at position 40 is NMD sensitive
(Figures 1 and 3C). Contrary to this prediction, we ob-
served that the 14/40 mRNA is expressed at levels com-
parable to those of the 14 and WT mRNAs, while 40
mRNA is expressed at 30% of the normal control (Figure
3C). UPF1 depletion of the transfected cells normalized the
levels of 40 mRNA as expected, but had no impact on the
accumulation of the 14/40 or 14 mRNA. This set of data
shows that PTC read-through does not occur and thus can-
not account for the NMD resistance of the AUG-proximal
nonsense-mutated -globin mRNAs.
The boundary of the AUG-proximity effect for NMD resis-
tance is impacted by the ORF sequence
Although human - and -globin genes derive from the
same ancestral gene and share a similar structure and func-
tion, the respective mRNAs are distinct in sequence, with
a strong divergence in the structures of the correspond-
ing 5′ UTRs. This difference in sequence is likely to con-
tribute to the lower efficiency for initiating translation in
-globin mRNA (52). Knowing that NMD mechanisms
are translation-dependent, we hypothesized that the differ-
ence in the boundary of the AUG-proximity effect for -
and -globin mRNAs might reflect their respective trans-
lation initiation efficiencies. This hypothesis was tested by
replacing the 5′ UTR of -globin with that of the -globin
mRNA in WT, 27 and 40 genes, generating three hy-
bridmRNAs: 5′ UTR-/WT, 5′ UTR-/27 and 5′ UTR-
/40 (Figure 4A). mRNA quantification of these tran-
scripts transiently expressed in HeLa cells showed that the
partial NMD inhibition observed for 27 mRNA––it accu-
mulates at 71% of WTmRNA (Figure 4B)––is maintained
in 27 mRNAs with the -globin 5′ UTR (5′ UTR-/27
mRNA is 67% of the WT).
Next, we tested whether the ORF sequence affects the
boundary of the AUG-proximity effect. Thus, in WT,
the entire sequence upstream of codon 27 was replaced
by the corresponding sequence of WT or 26, creating
the WT26/ and 26/‘27’ constructs, respectively. In
40 gene, the entire sequence upstream of codon 27 was
replaced by the corresponding sequence of WT, gener-
ating the WT26/40 gene (Figure 4A). Moreover, these
latter hybrid genes were further altered by replacing the
5′ UTR of -globin for that of -globin, originating the
5′ UTR-/WT26/, 5′ UTR-/26/‘27’ and 5′ UTR-
/WT26/40 constructs (Figure 4A). Our results show
that 27 mRNAs become fully committed to NMD if they
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Figure 3. The -globin mRNA does not allow PTC read-through. (A) Schematic representation of the studied human -globin mRNAs. Vertical lines
represent translation initiation (AUG) or termination [native (UAA) or premature (PTC)] codons. The name of each transcript is specified on the right.
(B) Western blotting analysis of protein samples obtained from HeLa cells transiently transfected with constructs carrying the wild-type -globin gene
(WT), or a -globin gene nonsense-mutated at codons 14 (14), 40 (40) or 14 and 40 (14/40). Cells were subjected to single knockdown of UPF1
(UPF1 siRNA) or treated with control siRNA targeting firefly Luciferase (Luc siRNA). Anti-UPF1 and anti--tubulin (control) antibodies were used as
indicated. (C) Using these cells, mRNA levels were determined by RT-qPCR using primers specific for human -globin gene and for puromicin-resistance
(puroR) gene. Quantification was performed by the relative standard curve method. Histogram represent fold-change of each sample relative to the control
(WTLuc siRNA) arbitrarily set to 100%. All values are normalized internally to puroR mRNA levels [SD are shown (n= 3)]. The P-values from student’s
t-tests are also shown. Except otherwise indicated, P-values refer to the comparison with the wild-type control transcript levels treated with control siRNA
(WT Luc siRNA).
carry the -globin ORF sequence, regardless of the 5′ UTR
sequence (Figure 4B). As a control for NMD, we observed
that hybrid transcripts nonsense-mutated at position 40 (5′
UTR-/40,WT26/40 and 5′ UTR-/WT26/40) ac-
cumulate at levels equivalent to those of 40 mRNA (43%,
43%, 40% and 37% of the WT mRNA, respectively), all
being fully committed to decay.
The reciprocal approach was also used. The 5′ UTR of
-globin was replaced by the -globin 5′ UTR in the WT,
26 and 39 genes, creating the 5′ UTR-/WT, 5′ UTR-
/26 and the 5′ UTR-/39 constructs, respectively (Fig-
ure 4C). Analysis of these constructs revealed that the 26
and 39 low mRNA levels are preserved if the transcripts
carry the -globin 5′ UTR (Figure 4D).
Moreover, in the WT gene, the entire sequence up-
stream of codon 27 was replaced by the corresponding se-
quence of WT or 27 genes, creating the WT27/ and
the 27/‘26’ genes, respectively; in the 39 gene, the entire
sequence upstream of the codon 27 was replaced by the cor-
responding sequence of WT, originating the WT27/39
gene (Figure 4C). Additionally, the 5′ UTR of -globin was
replaced by the -globin 5′ UTR in the latter three hy-
brid genes, which originated the 5′ UTR-/WT27/, 5′
UTR-/27/‘26’, and 5′ UTR-/WT27/39 constructs
(Figure 4C). Results show that if 26 mRNA carries the
-globin ORF, irrespectively of the 5′ UTR, the mRNA
levels significantly increase from 32% to 58% (27/‘26’
mRNA) or 55% (5′ UTR-/27/‘26’ mRNA), relatively
to the WT mRNA level (Figure 4D).
The analysis of these hybrid mRNAs leads us to make
two conclusions. First, we find that the sequence of the 5′
UTRhas no impact on determining the NMD sensitivity of
the transcript. Second, these results reveal an important role
of the ORF sequence in determining the full NMDcommit-
ment, and thus in determining the exact boundary of the
AUG-proximity effect.
The mRNA secondary structure dictates the boundary of the
AUG-proximity effect
The rate of translation elongation is sensitive to secondary
and higher order structures of the translated ORF (53).
Structural constraints of mRNA, such as stem-loops or
pseudoknots, are known to retard the progression of elon-
gating ribosomes (54). We have previously demonstrated
that insertion of a pseudoknot (43) into the ORF of -
globin mRNA containing an AUG-proximal PTC, converts
it from NMD resistant to NMD sensitive (21). This re-
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Figure 4. The sequence of the ORF determines the extension of the AUG-proximity effect. (A) Physical maps of the -globin and the hybrid /- and
//-globin mRNAs studied. Dark-gray rectangles represent -globin exons and light-gray rectangles represent -globin sequences. Translation initia-
tion codons (AUG) and native termination codons (UAA) or premature translation termination codons (PTCs) are depicted by heavy black vertical lines.
The name of each mRNA is indicated to its right. (B) Representative RPA using RNA isolated from HeLa cells transiently transfected with the constructs
specified beneath each lane. The identification of -globin and the puromycin-resistance (puroR) protected fragments is indicated to the left of the autora-
diograph. Levels of -globin mRNA were quantified relatively to the puroR mRNA, and these values are plotted above each respective lane (average and
standard deviations from three independent experiments). mRNA levels are normalized to the expression level of the wild-type mRNA (WT). A 2-fold
RNA sample (2x WT) from HeLa cells transfected with a WT gene was also analyzed to demonstrate that the experimental RPA was carried out in
probe excess. P-values were estimated using a student’s t-test. Except otherwise indicated, P-values refer to the comparison with the corresponding original
nonsense-mutated transcript levels, after normalization to the wild-type control. (C) Schematic representation of the studied -globin and hybrid /- and
//-globin mRNAs, using the same depiction code as for (A) (see above). (D) Illustrative RPA of RNA fromHeLa cells transiently transfected with the
constructs identified beneath each lane. Identification of the -globin and puroR protected fragments is indicated to the left of the autoradiograph. Average
levels (and standard deviations from three independent experiments) of -globin mRNA (plotted above each respective lane) were measured relatively to
the puroR mRNA as in (B) (see above). Except otherwise indicated, P-values refer to the comparison with the corresponding original nonsense-mutated
transcript levels, after normalization to the wild-type control.
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sponse and data from Figure 4, suggested a model in which
the time taken by the ribosome to translate the ORF dic-
tates the boundary of the AUG-proximity effect. To fur-
ther explore this potential determinant of NMD and the
determinants of the boundary of the AUG-proximity ef-
fect, we next replaced the first 25 codons of the 26 gene
by a tandem array of 25 ‘CAA’ repeats, which has been
shown to facilitate rapid translation elongation (55), cre-
ating the 26-(CAA)25 construct (Figure 5A). Knowing
that the boundary of the AUG-proximity effect in the h-
globin mRNA is located between codons 23 and 25, the
unstructured sequence when inserted upstream of the 26
PTC should inhibit NMD and shift the boundary of the
AUG-proximity effect further downstream. The first 25
codons of the WT, and 39 control genes were also re-
placed, creating the WT-(CAA)25, and 39-(CAA)25 con-
structs, respectively (Figure 5A). mRNA secondary struc-
tures predicted by MFOLD (http://mfold.bioinfo.rpi.edu/
cgi-bin/rna-form1.cgi) show that while the 26 mRNA has
a minimal free energy of −232.50 kcal/mol, introduction
of the (CAA)25 unstructured segment makes this mRNA to
increase its minimal free energy to −199.90 kcal/mol. Our
analysis of mRNA accumulation shows that the altered 26
mRNA [26-(CAA)25] increased from 40% to 82% of the
wild-type control (Figure 5B). In contrast, the unstructured
insertion did not relieve NMD in the 39 mRNA: 39, and
39-(CAA)25 mRNAs accumulate at similar levels, respec-
tively at 37%, and 33% of the WT transcript (Figure 5B).
As expected, expression of both 39 mRNAs was brought
toWT levels inUPF1-depleted cells (Supplementary Figure
S4).
To further relate ORF structure to AUG-proximity
boundary, using the -globinmRNAs, we introduced either
a pseudoknot-inducing sequence or an unstructured CAA
repeat in the ORF. The pseudoknot was introduced into
WT, 25, 27 and 40 genes, replacing the first 19 codons
of these constructs (Figure 5C).MFOLD predicted that the
pseudoknot induces a significant change in theminimal free
energy from−231.60 kcal/mol (25) and−225.10 kcal/mol
(27) to −241.20 kcal/mol and −228.40 kcal/mol, respec-
tively. In parallel, the unstructured (CAA)26 repeats were
introduced into the WT, 27 and 40 mRNAs (see Fig-
ure 5C) changing the minimal free energy of the h-globin
mRNAs from−225.10 kcal/mol to−185.70 kcal/mol. The
analyses of mRNA accumulation revealed that the pseudo-
knot structure introduced into the 25 gene (25-pk gene)
resulted in a significant reduction of the encoded mRNA
accumulation levels (Figure 5D). Identical outcomes were
obtained when the pseudoknot structure was inserted in
cis to the PTC at position 27 (Figure 5D). In contrast, the
unstructured ORF consisting in 26 ‘CAA’ repeats inserted
into the 27 mRNA [27-(CAA)26 mRNA] significantly in-
creased the mRNA levels from 66% to 98%, relatively to
the WT (Figure 5D). As expected, in the context of a
transcript with a PTC further downstream already NMD-
sensitive (40), the pseudoknot structure, or the (CAA)26
unstructured ORF, does not affect levels of mRNA accu-
mulation (Figure 5D). These results lead us to conclude
that the sensitivity of mRNAs with AUG-proximal PTCs
to NMD is impacted by the strength of secondary structure
preceding the PTC; the presence of a pseudoknot increases
NMD sensitivity and the presence of an unstructured ORF
decreases NMD sensitivity.
Knowing that h-globin transcripts carrying an AUG-
proximal PTC, such as the 27 mRNA, allow for effi-
cient downstream translation re-initiation, which is par-
tially responsible for their NMD inhibition (Figure 2), we
next investigated the outcome of the (CAA)26 unstruc-
tured ORF independently of the translation re-initiation ef-
fect. For that, we introduced the 26 consecutive ‘CAA’ re-
peats into the WT.32–76Met→Thr, 27.32–76Met→Thr
and 40.32–76Met→Thr genes. Under these conditions,
the presence of the (CAA)26 segment into the ORF of the
27 mRNA makes it to increase from 57% to 79% of the
WT mRNA level (Figure 5D). These results are paral-
lel to those obtained when translation re-initiation is al-
lowed (Figure 5D). In fact, by comparing results obtained
in both conditions, we observe that the presence of the un-
structured ORF into the 27 mRNA makes a 1.5-fold in-
crease in mRNA levels. Thus, our data show that in the 27
transcripts, the unstructured ORF enhances NMD inhi-
bition independently of translation re-initiation. However,
it is worth noticing that the accumulation levels for 27
and 27-(CAA)26 mRNAs are higher when translation re-
initiation is allowed (Figure 5D). These results show that
under conditions where translation re-initiation can occur,
NMD inhibition is stronger as it results from two different
effects: translation re-initiation and the AUG-proximity ef-
fect. In addition, the AUG-proximity effect for NMD in-
hibition is more prominent when the ORF has an unstruc-
tured sequence.
To confidently ascribe the impact of the pseudoknot and
CAA repeats to their impact on translational elongation,
we next confirmed that in fact the unstructured ORF de-
creases the time taken by the ribosome to translate theORF,
while the pseudoknot sequence in the ORF increases the
time of translation elongation. For that, the -globin se-
quence downstream of the codon 32, in 27, 27-(CAA)26,
and 27-pk gene constructs, was replaced by the firefly lu-
ciferase (Luc) ORF, creating 27/Luc, 27-(CAA)26/Luc,
and 27-pk/Luc genes, respectively (Figure 5E). To nor-
malize results to the effectiveness of the 32Met codon to
initiate translation, we used the AUA27/Luc gene that has
the first AUG mutated to AUA (Figure 5E). Luciferase ac-
tivities were measured and normalized to the mRNA lev-
els of the corresponding construct to obtain translation ef-
ficiencies. Results show that the unstructured ORF leads to
the production of more luciferase protein than the 27/Luc
mRNA, since luciferase activity from 27-(CAA)26/Luc
mRNA is at 153% of that from 27/Luc (Figure 5E). On
the other hand, the 27-pk construct allows for 67% of rel-
ative luciferase activity comparing to that from 27/Luc
mRNA (Figure 5E). Knowing that efficiency of translation
re-initiation is directly proportional to the elongation rate
(50), our data show that the (CAA)26 sequence in the ORF
allows a higher elongation rate than the 27 or pseudoknot
sequences. Taken our results together, we can conclude that
the ORF secondary structure by affecting the elongation
rate, dictates the boundary of the AUG-proximity effect for
NMD inhibition.
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Figure 5. The boundary of the AUG-proximity effect for NMD resistance is determined by the mRNA secondary structure. (A) Schematic representation
of the studied human -globin mRNAs. Heavy black vertical lines indicate the positions of translation initiation codons (AUG) and natural (UAA)
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DISCUSSION
In general, nonsense codons located more than 50–55 nts
upstream of the 3′-most exon–exon junction elicit NMD
in mammalian cells (47,48). However, our previously re-
ported data have shown that human -globin transcripts
carrying nonsense mutations in the 5′ region of exon 1 accu-
mulate to levels comparable to those of wild-type -globin
mRNA (40). This ability of mutated -globin mRNA to es-
cape NMD was demonstrated to depend on the distance of
the nonsense codon to the initiator AUG (21,41,46) and,
accordingly, it was named the ‘AUG-proximity effect’. Ad-
ditional data have supported that this effect is due to the
influence of PABPC1, which seems to be brought into the
proximity of an early PTC during cap-dependent transla-
tion and 43S scanning (21,34). Although this effect has not
been observed in budding and fission yeast (56,57), it seems
to be a general attribute in mammalian cells (21); these dif-
ferences might reflect differences in the NMD determinants
that appeared during evolution. For example, contrary to
what occurs in mammalian cells, in S. pombe, the important
NMDdeterminant is the proximity of the PTC to an intron,
being modest the contribution of the distance between the
PTC and PABPC1 (57).
The aim of this study was to analyze if human - and
-globin mRNAs share similar NMD profiles. Being two
highly related genes, - and -globin preserve a similar gen-
eral organization, and the encoded peptides form a com-
parable structure and accomplish an equivalent function.
Therefore, it is not surprising that they share the overall
NMD behavior, and the AUG-proximity effect for NMD
inhibition observed in -globin (Figure 1B) was also found
in -globin mRNA (Figure 1C). However, we have ob-
served that this effect occurs for PTCs located further down-
stream (until codon 30) in the -globin mRNA (Figure 1).
On the other hand, contrary to what is observed for -
globin mRNA, the human -globin mRNA exhibits effi-
cient translation re-initiation at a downstream AUG, for
example at codon 32 (Figure 2 and reference 46). Trans-
lation re-initiation contributes to NMD inhibition, as ob-
served in Figure 2B. However, the degree of translation re-
initiation observed in short ORF-containing -globin tran-
scripts is insufficient to explain the full outcome of NMD
inhibition (Figure 2B). Indeed, our results show that NMD
inhibition observed in -globin transcripts carrying a short
ORF is due to both the AUG-proximity effect and transla-
tion re-initiation, while for -globin transcripts carrying an
AUG-proximal PTC, NMD inhibition is fully explained by
the AUG-proximity effect as translation re-initiation is very
modest (Figure 2C). The potential role of translation re-
initiation in NMD resistance of AUG-proximal nonsense-
mutated -globin mRNAs has been the subject of a pre-
vious study (51). In that study, the NMD-resistance of -
globin AUG-proximal nonsense-mutated mRNAs was at-
tributed to efficient translation re-initiation downstream of
the PTC. It may be of importance, however, to note that
the interpretation of these studies is complicated by the use
of a -globin gene in which exon 1 was transformed into a
functional exon 2 by the introduction of an exogenous in-
tron into the 5′ UTR. The expression of this recombinant -
globin gene, even lacking a PTC, was repressed when com-
pared to the normal -globin transcript (51). In contrast,
by using globin genes with native structures, we have found
that even in cases in which we do detect some level of trans-
lation re-initiation downstream of the AUG-proximal PTC,
site-specific elimination of the re-initiation codons fails to
fully restore NMD-sensitivity (46). Thus, while a contribu-
tion of translation re-initiation in NMD-evasion cannot be
completely ruled out in any particular circumstance, our de-
tailed analyses of the human -globin gene lead us to con-
clude that the AUG-proximity is a major inhibitor of the
NMD pathway.
Our results show that the boundary of the AUG-
proximity effect for NMD inhibition in the human - and
-globin transcripts is determined by each of the ORF
secondary structure (Figure 4) that, in turn, affects the
time of translation elongation. In fact, an unstructured
ORF speeds up progression of elongating ribosomes and
inhibits decay of an otherwise NMD-sensitive nonsense-
mutated transcript (Figure 5). On the contrary, a complex
secondary structure present in a short ORF retards pro-
gression of elongating ribosomes and increases NMD effi-
ciency in an otherwise NMD-insensitive nonsense-mutated
transcript (Figure 5). Knowing that the mRNA secondary
structure is involved in determining the overall rate of trans-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
or premature termination codons (PTCs). Diagonally-striped rectangles represent 25 consecutive ‘CAA’ triplets [(CAA)25]. The identification of each
transcript is indicated to the right. (B) Representative RPA of RNA isolated from HeLa cells transiently transfected with the constructs specified beneath
each lane. The identification of -globin and the puromycin-resistance (puroR) protected fragments is indicated to the left of the autoradiograph. Levels of
-globin mRNA were quantified relatively to the puroR mRNA, and these values are plotted above each respective lane (average and standard deviations
from three independent experiments) normalized to the expression level of WT mRNA. A 2-fold RNA sample (2x WT) from HeLa cells transfected
with the WT gene was also analyzed to ascertain that the RPA was carried out in probe excess. P-values were determined using a student’s t-test. Except
otherwise indicated, P-values refer to the comparison with the corresponding original nonsense-mutated transcript levels, after normalization to the wild-
type control. (C) Schematic representation of the studied human-globinmRNAs, using the same depiction code as for (A) (see above). Loop shapes in dark
rectangles represent pseudoknot (pk) structures. The alteration of the two potential re-initiating AUGs, at codons 32 and 76, to ACG triplets is indicated
by short and thick vertical lines (32–76Met→Thr). The identification of each mRNA is indicated to the right of the diagram. (D) Representative RPA
using RNA isolated from HeLa cells transiently transfected with the constructs specified beneath each lane. The positions of -globin and the puromycin-
resistance (puroR) protected fragments are indicated to the right of the autoradiograph. Resulting levels of -globin mRNA were quantified as in (B).
Except otherwise indicated, P-values refer to the comparison with the corresponding original nonsense-mutated transcript levels, after normalization to
the wild-type control. (E) Luminometry assay to test translation re-initiation after translation of a highly structured (pseudoknot; pk) or unstructured
[(CAA)26] ORF. The 5′-part of -globin gene upstream of codon 32 (AUG), was fused with the firefly luciferase ORF at its translation initiation codon.
Volume-shaped rectangles represent luciferase exons, dark-gray rectangles represent -globin sequences. The initiation or potential re-initiation, as well
as termination [native (UAA) or premature (UAG)] codons, are represented as black vertical lines. A control construct was created, in which the -globin
translation initiation codon was mutated to AUA allowing to control for the maximum of luciferase activity. HeLa cells were transiently cotransfected with
firefly and Renilla luciferase-containing plasmids and protein levels were analyzed as above for Figure 2C.
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Figure 6. Amodel for the effect of an AUG-proximal premature termination codon (PTC or stop codon). (A) The effect in the human -globin transcript.
During cap-mediated translation initiation, cytoplasmic poly(A) binding protein 1 (PABPC1) interacts with the eukaryotic initiation factor 4G (eIF4G).
This interaction indirectly tethers PABPC1 to the 40S ribosomal subunit via the interaction of eIF4Gwith eIF3, which interacts with the 40S. The resulting
configuration brings PABPC1 into the vicinity of the AUG initiation codon as a consequence of 43S scanning. The maintenance of the PABPC1-eIF4G-
eIF3 interactions with the 40S during the first steps of translation elongation brings PABPC1 into close proximity with the termination complex at an
AUG-proximal PTC. This proximity allows PABPC1 to interact with the release factor eRF3, thus impairing the UPF1-eRF3 interaction, resulting in
efficient translation termination and inhibition of NMD––this was called the ‘AUG-proximity effect’. (B) In the human -globin transcript, the AUG-
proximity effect is observed for PTCs located further downstream because the open reading frame (ORF) is less structured. The more relaxed structure
allows a faster elongation rate resulting in a longer window of the AUG proximity effect. In addition, the brief ORF translation also allows efficient
translation re-initiation to occur at codon 32. This re-initiation diminishes the levels of residual exon junction complexes on the mRNA, thus contributing
to the overall repression of NMD.
lation, since mRNA unwinding causes prolonged ribosome
pausing (53,54), results herein suggest that the rate of trans-
lation elongation might be higher in - than in -globin
transcripts, given that the boundary of the AUG-proximity
effect is located further downstream in the-globinmRNA.
In normal individuals, the average /-globinmRNA ra-
tio is about 1.3 (58). Of interest, nearly 70% of -globin
mRNA ismainly found in pre-initiation complexes, whereas
about 50% of total -globin mRNA is associated with ac-
tively translating 80S ribosomes (52). These data suggest
that -globin manifests an inefficient or at least delayed
translation initiation. Therefore, -globin mRNA may ac-
tually have a higher translation elongation rate than -
globin mRNA to assure a correct balance between the syn-
thesized - and -globin chains. On the other hand, the -
globin gene is known to possess a high G+C content and
this feature leads to a strong union of the DNA double
strand. In fact, the -globin gene cluster presents in aver-
age about 60%G+C content and the -globin cluster about
40% (59). The average G+C content in the non-repetitive
fraction of the human genome is also about 40% (60,61).
Moreover, the average G+C content of the -globin cDNA
has been determined to be around 62% and that of -globin
cDNA around 51% (62). Thus, it would be expected that
the -globin mRNA could present a secondary structure
more robust than that of -globin mRNA. However, this
is apparently not the case, since data regarding the opti-
mal mRNA secondary structure and associated minimum
free energy prediction, using the MFOLDWeb Server soft-
ware, attribute a more stable secondary structure to the -
globin mRNA (−230.60 kcal/mol for -globin mRNA ver-
sus −224.80 kcal/mol for -globin mRNA). The more un-
stable secondary structure of the -globin mRNA is also in
accordance with the possibility of this transcript to present
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a higher translation elongation rate than that observed for
the -globin mRNA, and this supports our present data.
The relevance of the time taken to translate a short ORF
is related to the fact that some initiation factors appear to
remain ribosome-associated for the first moments of the
ORF translation elongation (43,50,63,64). Thus, if the elon-
gation phase is brief, the ribosomemay reach the translation
termination codon before it has had time to discharge initi-
ation factors and other associated proteins. When the ribo-
some arrives at the stop codon during translation of a short
ORF, it might still hold the interaction with eIF4G, due
to the brief translation, and PABPC1 might remain bound
to eIF4G as well. The proximity of PABPC1 at the end of
translation has been shown to promote correct termination
and to inhibit NMD activation in human cells (21–24,65)
as it competes with UPF1 to interact with eRF3 at the ter-
mination complex (7,26,34). The inability of UPF1 to bind
eRF3 prevents the interaction between the premature ter-
mination complex and UPF2/UPF3 at a downstream EJC,
which results in the repression of NMD. The hypothesis of
the time taken by the ribosome to translate a short ORF
being a major determinant of NMD inhibition can be sum-
marized as follows: during a brief cap-mediated translation
of a short ORF, PABPC1 might be in close proximity to the
ribosome until it reaches the termination codon. In this sit-
uation, PABPC1 may interact with eRF3 and preclude the
binding of UPF1 to eRF3, thus preventing NMD activa-
tion (Figure 6A). In fact, this model is also in accordance
with our previous data (34). This effect will be much more
downstream extended if the short ORF is unstructured than
if it is a well-structured one. In the unstructured ORF, the
ribosome is faster and elongates too further downstream
before the initiation factors, such as eIF4G-PABPC1, are
disassembled; in addition, by the time the ribosome reaches
the PTC, PABPC1 can interact with eRF3 at the terminat-
ing complex, which inhibits NMD (Figure 6B). Alterna-
tively, and in accordance with recent data (36,37), PABPC1-
bound eIF4Gmight be the player that represses NMD. Ac-
tually, a brief ORF translation, which allows the retention
of some initiation factors by the time the ribosome reaches
the stop codon, may explain both the AUG-proximity effect
(reflecting the proximity of PABPC1 to the PTC) and trans-
lation re-initiation, when the transcript is permissive to both
mechanisms (Figure 6B). In fact, the resumption of scan-
ning and re-initiation also require a cap-mediated transla-
tion initiation with the participation of eIF4F, and most
likely depends on the preservation of eIF4F, at least the cen-
tral one-third fragment of eIF4G, and eIF3 associated with
the ribosome throughout translation of theORF (50,64,66).
Our observation that an unstructured ORF in the -globin
mRNAs enhances NMD inhibition due to both the AUG-
proximity effect and translation re-initiation further sup-
ports this notion. However, for translation re-initiation to
occur it is necessary that the intercistronic sequence and
the re-initiation codon are favorable (50), and this does not
seem to be the case in the -globin mRNA. In addition,
UPF1 seems to play a role in the efficiency with which ribo-
somes are released from the mRNA after translation termi-
nation (39). This effect is likely to modulate the efficiency
of translation re-initiation (39). Our results therefore sug-
gest that - and -globin mRNAs differently interact with
UPF1. The identification of additional features that deter-
mine efficient translation re-initiation in -globin but not in
-globin AUG-proximal nonsense-mutated transcripts will
be further studied.
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